ICON's short interest — meaning the percentage of the share float that is being shorted — is lower than average at 1.9%. The ...

The sweet smile on Siena Hale’s pretty face melts the hearts of those she encounters. Her inquisitive eyes quickly scan the ...

Momentum continues to build for Lamassu Biotech's pioneering treatment protocol for acute pancreatitis in canines. The private, clinical stage biopharmaceutical company has received a $2.7 million ...

(Reuters) -Merck has held talks to buy Swiss biotech MoonLake Immunotherapeutics for more than $3 billion, the Financial ...

Tariffs could be a hidden opportunity for packaging professionals to re-evaluate and diversify suppliers.

The process is called extracellular respiration, which mimics how batteries discharge electric current -- allowing bacteria ...

Using flawed studies and scientific journal publications, abortion opponents are building a body of research meant to ...

Already, fans have flocked to read “Great Big Beautiful Life” by Emily Henry, “Flirting Lessons” by Jasmine Guillory, “Summer ...

A US-based biotech company has successfully sequenced the genetic codes of preserved plants, some of which date back more ...

The global contract research organization (CRO) services market is expected to witness a growth rate of 9% in the next five ...

The rise of GLP-1 agonist therapies has transformed obesity treatment, delivering unprecedented results and revealing their ...

A movement’s beloved squirrel is being unveiled as a heroic MAGA icon in New York’s Chelsea gallery district. In “Opposing ...